Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

high-grade neuroendocrine carcinoma of the cervix uteri - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

high-grade neuroendocrine carcinoma of the cervix uteri

MONDO:0016276

Also known as:high-grade neuroendocrine carcinoma of the uterine cervixpoorly differentiated neuroendocrine carcinoma of the cervix uteripoorly differentiated neuroendocrine cervical carcinoma

Overview

High-grade neuroendocrine carcinoma of the cervix uteri is a rare, aggressive, primary cervical neoplasm, originating from neuroendocrine cells present in the lining epithelium of the cervix, characterized, macroscopically, by usually large lesions, sometimes with a barrel-shaped appearance. Patients often present with abnormal vaginal bleeding or discharge, pelvic/abdominal pain, post-coital spotting and/or dysuria, while symptoms related to carcinoid syndrome are not frequent.

Diagnosis

Biomarker and diagnostic research for high-grade neuroendocrine carcinoma of the cervix uteri has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for high-grade neuroendocrine carcinoma of the cervix uteri.

75 publications have been identified in PubMed for high-grade neuroendocrine carcinoma of the cervix uteri. Research spans Case Report / Case Series (39%), Review / Meta-Analysis (19%), and Epidemiology / Natural History (14%).

Research Type	Count	% of Total
Patient case studies	29	39%

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:213777

GARD

Genetic and Rare Diseases Info Center

GARD:20489

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

high-grade neuroendocrine carcinoma of the cervix uteri

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications